Diagnosis At Earliest Stage For Majority Of Kidney Cancers

                   
medicalnewstoday.com     May 20, 2008            

Patients in the United States today are now much more likely to be diagnosed with smaller tumors, in the earliest, most treatable stage of kidney cancer than a decade ago, leading to a slightly higher survival rate, according to the results of a national study led by a UC San Diego Medical Center... [read full story]                    

FULL COVERAGE
                   

Kidney Cancers More Likely to Be Diagnosed Early

kltv.com     May 20, 2008          

MONDAY, May 19 (HealthDay News) -- Compared to a decade ago, kidney cancer patients in the United States are much more likely to be diagnosed with smaller tumors in the earliest, most treatable stage of the disease, resulting in a slightly higher survival rate. Researchers analyzed the records of...                    

comments

                   

New drug fights kidney cancer progression

upi.com     May 20, 2008          

NEW YORK, May 20 (UPI) -- A U.S. study has found an experimental targeted drug therapy significantly delays cancer progression in patients with metastatic kidney cancer. The data from the international, multicenter Phase III clinical trial found the drug, everolimus, significantly delays cancer...                    

comments

                   

New drug fights kidney cancer progression

politicalgateway.com     May 20, 2008          

NEW YORK, May 20 (UPI) -- A U.S. study has found an experimental targeted drug therapy significantly delays cancer progression in patients with metastatic kidney cancer. The data from the international, multicenter Phase III clinical trial found the drug, everolimus, significantly delays cancer...                    

comments

                   

Kidney Cancers More Likely to Be Diagnosed Early

medicinenet.com     May 20, 2008          

MONDAY, May 19 (HealthDay News) — Compared to a decade ago, kidney cancer patients in the United States are much more likely to be diagnosed with smaller tumors in the earliest, most treatable stage of the disease, resulting in a slightly higher survival rate. Researchers analyzed the records of...                    

comments

                   

Cancer's Cruel Economics

businessweek.com     May 21, 2008          

Billions of dollars are spent developing cancer drugs, but precious few get approved. Steven Creel beat kidney cancer with Oncophage, but FDA approval looks unlikely Alexander Gronsky Dr. Oleg Loran treats kidney cancer, but he doesn't have much to offer his patients. So Loran was relieved in...                    

comments

                   

The Battle Over New Cancer Drugs

cbsnews.com     May 22, 2008          

Why Does It Take So Much Time - The reason has to do with the way the FDA approves cancer treatments, CBS News medical correspondent Dr. Jon LaPook reports. However, Antigenics, the vaccine maker, looked a group of patients in the trial who received the vaccine when their cancer was in its early...                    

comments

                   

The FDA's Cancer Chief Speaks Out

businessweek.com     May 22, 2008          

In a discussion with BusinessWeek, Dr. Richard Pazdur talks about clinical trials, small biotechs, and anxious patients Dr. Richard Pazdur, 55, is one of the most powerful men in medicine. An oncologist by training, he has overseen the U.S. Food & Drug Administration's cancer drug division since...                    

comments

                   

The FDA's Cancer Chief Speaks Out

redorbit.com     May 22, 2008          

Posted on: Thursday, 22 May 2008, 11:53 CDT Dr. Richard Pazdur, 55, is one of the most powerful men in medicine. An oncologist by training, he has overseen the U.S. Food & Drug Administration's cancer drug division since 1999, and in 2005 was named director of the FDA's newly created Office of...                    

comments

The 'Anatomy' of Clinical Trials: 'Grey's' Season Finale Leaves Public in the Dark About the...

prnewswire.com     May 22, 2008          

PHILADELPHIA, May 22 /PRNewswire/ -- "Cancer clinical trials are highly-structured and follow a well-defined protocol with careful supervision," said Robert L. Comis, MD, President and Chairman of the Coalition of Cancer Cooperative Groups. "Trials can provide patients at all stages of cancer...                    

comments

New cancer drug developed in Utah shows promise

abc4.com     May 23, 2008          

SALT LAKE CITY (ABC 4 News) - A new cancer treatment, developed here in Utah, is showing promising results in early trials. The pill was developed by SuperGen and is called MP-470. While the name may not be very exciting, those who are using it in the first trials are very enthusiastic about the...                    

comments